Number | Percentage (%) | |
---|---|---|
Gender | ||
Male | 19 | 57.6 |
Female | 14 | 42.4 |
Age | ||
≤ 50 | 3 | 9.1 |
51–60 | 9 | 27.3 |
61–70 | 12 | 36.4 |
> 70 | 9 | 27.2 |
Smoking | ||
Yes | 18 | 66.2 |
No | 15 | 33.8 |
Comorbidity lung diseases | ||
COPD | 20 | 60.6 |
Bronchiectasis | 5 | 15.2 |
Silicosis | 2 | 6.1 |
Tuberculosis | 6 | 18.1 |
Location of lung cancer | ||
Trachea | 12 | 36.4 |
Carina of trachea | 4 | 12.1 |
Left bronchi | 4 | 12.1 |
bronchi | 13 | 39.4 |
Cell type of the tumors | ||
Squamous cancer | 21 | 63.6 |
Adenocarcinoma | 12 | 36.4 |
Combined with chemotherapy | ||
Yes | 16 | 48.5 |
No | 17 | 51.5 |
Grade of airway obstruction * | ||
III | 2 | 6.1 |
IV-V | 31 | 93.9 |
TNM stages | ||
Stage II | 6 | 18.2 |
Stage III | 7 | 21.2 |
Stage IV | 20 | 60.6 |
KPS score prior to the treatment | ||
50–59 | 9 | 27.3 |
40–49 | 14 | 42.4 |
30–39 | 10 | 30.3 |